LNTHLantheus Holdings, Inc.

Nasdaq lantheus.com


$ 94.97 $ -0.19 (-0.2 %)    

Friday, 16-Aug-2024 15:59:58 EDT
QQQ $ 475.24 $ 0.61 (0.13 %)
DIA $ 406.80 $ 0.86 (0.21 %)
SPY $ 554.24 $ 1.24 (0.22 %)
TLT $ 97.41 $ 0.34 (0.35 %)
GLD $ 231.90 $ 5.08 (2.24 %)
$ 94.91
$ 94.91 x 100
$ 94.98 x 200
-- - --
$ 50.20 - $ 126.89
488,780
na
6.7B
$ 1.23
$ 15.64
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 04-29-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 04-30-2020 03-31-2020 10-Q
19 02-25-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 07-25-2019 06-30-2019 10-Q
22 04-30-2019 03-31-2019 10-Q
23 02-20-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 05-02-2018 03-31-2018 10-Q
27 02-26-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-01-2017 06-30-2017 10-Q
30 05-02-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 11-01-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-03-2016 03-31-2016 10-Q
35 03-02-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jmp-securities-maintains-market-outperform-on-lantheus-holdings-lowers-price-target-to-125

JMP Securities analyst David Turkaly maintains Lantheus Holdings (NASDAQ:LNTH) with a Market Outperform and lowers the price...

 truist-securities-maintains-buy-on-lantheus-holdings-lowers-price-target-to-135

Truist Securities analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and lowers the price target ...

 lantheus-cuts-fy24-adj-eps-outlook-form-700-720-to-660-670-vs-707-estimate-maintains-revenue-outlook-of-150b-152b-vs-151b-estimate

Full Year 2024 Financial Guidance   Guidance Issued July 31, 2024 Guidance Issued May 2, 2024 FY 2024 ...

 lantheus-q2-2024-adj-eps-180-misses-183-estimate-sales-394091m-beat-382153m-estimate

Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.80 per share which missed the analyst consensus estimate of $...

 b-riley-securities-maintains-buy-on-lantheus-holdings-raises-price-target-to-146

B. Riley Securities analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target fr...

 jones-trading-maintains-buy-on-lantheus-holdings-raises-price-target-to-137

Jones Trading analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target from $12...

 russell-2000-marks-fifth-day-of-gains-whats-driving-surge-in-small-cap-stocks

Small-cap stocks, including Comfort Systems USA, Fabrinet, and Carvana, have rallied for 5 days, with iShares Russell 2000 ETF ...

 xpeng--quantumscape-are-among-top-11-mid-cap-stocks-that-performed-well-last-week-july-7-july-13-details

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeut...

 russell-2000-index-notches-strongest-week-of-year-hits-31-month-highs-outlook-is-clouded-by-feds-concerns-over-labor-market-analyst-warns

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-...

 truist-securities-maintains-buy-on-lantheus-holdings-raises-price-target-to-141

Truist Securities analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target ...

 leerink-partners-maintains-outperform-on-lantheus-holdings-raises-price-target-to-127

Leerink Partners maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and raises the price target from $106 to $127.

 new-reimbursement-rules-for-diagnostic-radiopharmaceuticals-is-undoubtedly-positive-for-lantheus-analyst

CMS proposes new Medicare payment rates for 2025, addressing diagnostic radiopharmaceutical costs. The proposed rule includes s...

 lantheus-expands-cancer-pipeline-with-35m-acquisition-of-rm2-rights

Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabli...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION